Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Athenex.
LIVE WEBCAST: Rapid Reviews in Oncology® from Chicago: Practice-Changing Data in Breast Cancer
Learners may enter the live webcast site starting at 7:30pm to take the online pretest.
The Rapid Reviews in Oncology® legacy format is a live, in-studio video broadcast to rapidly update physicians on data that will have been recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2019. Chaired by renowned breast cancer expert and leading clinical researcher Joyce O’Shaughnessy, MD, this live-stream broadcast will consist of a panel discussion of ground-breaking data. Emerging data with the potential to change treatment for patients will be presented and discussed across the continuum of breast cancer. The expert panel will highlight the implications and applications of these data for your practice, helping you optimize care for your patients with breast cancer.
The live webcast will be broadcast across the United States on June 19, 2019 at 8pm EDT. The enduring activity will be available online as an archived webcast from June 30, 2019, to June 30, 2020.Benefits of Attending
- Stay up-to-date on the latest data pertaining to treatment and management of breast cancer across the spectrum of disease
- Benefit from expert analysis of the most recent data likely to impact clinical practice in breast cancer management in the near future
- Learn how experts in breast cancer research place emerging data into clinical context for the treatment and management of patients with breast cancer
This educational activity is directed toward medical oncologists and fellows who treat patients with breast cancer. Surgical oncologists, radiation oncologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer are also invited to participate.
Upon successful completion of this activity, you should be better prepared to:
- Report recent evidence concerning novel treatment strategies from clinical trials conducted among patients with breast cancer
- Assess the importance of ongoing and completed clinical trials informing the management of patients with breast cancer
- Contextualize new evidence in the management of breast cancer in consideration of evolving treatment paradigms in the field
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Athenex.
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Co-Chair, Breast Cancer Research Program
The US Oncology Network
Registration2 Ways to Register
- Online: click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701.
2 Clarke Drive
Cranbury, NJ 08512
Registration Fee - Free
Disclosure Policy and Resolution of Conflicts of Interest
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).
Additionally, PER® is required by the ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, and management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support for this activity.
Instructions for This Activity & Receiving Credit
- You will need to log in to participate in the live webcast.
- The link below will take you to a Pretest. Complete the Pretest to advance to the live webcast page.
- In order to receive a CME certificate, you must complete the live webcast.
- At the conclusion of the live webcast, please click on the link that appears and proceed to the Posttest. An email will also be sent to registered users with a link to the Posttest.
- Follow the link and complete the Posttest with a score of 70% or higher, then complete the Evaluation and click on "Request for Credit." You may immediately download a CME Certificate upon completion of these steps.
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventive measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities, including providing proof at check in of being 2 weeks removed from receiving a full COVID-19 vaccination or results from a negative COVID-19 viral test taken no more than 3 days prior to the program.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.